Hepion PharmaceuticalsHEPA
那斯達克 · USD
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
盤後
0
0
(0%)
01/01 08:00 (UTC+8)
Hepion PharmaceuticalsHEPA
0
0
(0%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 1,280 | - | 4,459 | 8,504 | - | 10,409 | 10,665 | 14,166 | 13,210 | 9,773 |
研發費用 | 22 | -592 | 2,763 | 7,137 | 2,540 | 5,443 | 8,519 | 11,881 | 9,798 | 7,516 |
推銷及管理費用 | 1,258 | 1,794 | 1,696 | 1,367 | 2,643 | 1,776 | 2,146 | 2,285 | 3,412 | 2,257 |
非經常性項目費用 | - | - | - | - | - | 3,190 | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -1,281 | -1,202 | -4,458 | -8,504 | -5,182 | -10,409 | -10,665 | -14,166 | -13,209 | -9,773 |
其他收入及費用 | -4,800 | 473 | 67 | 4,529 | -636 | -1,058 | 140 | 88 | -48 | 80 |
利息費用 | 25 | 1,247 | - | -4 | 4 | 9 | 7 | 2 | 2 | 3 |
稅前純益 | -6,106 | -1,547 | -4,866 | -3,925 | -5,823 | -11,469 | -10,527 | -14,080 | -13,260 | -9,695 |
所得稅 | - | - | - | - | -2,969 | -409 | - | - | - | -2,884 |
稅後純益 | -6,106 | -1,547 | -4,866 | -3,925 | -2,854 | -11,060 | -10,527 | -14,080 | -13,260 | -6,811 |
基本每股稅後盈餘(元) | -2.15 | -0.18 | -0.72 | -0.68 | -0.56 | - | -2.74 | -3.68 | -0.17 | -0.13 |
稀釋每股稅後盈餘(元) | -2.15 | -0.17 | -0.73 | -0.69 | -0.56 | -2.42 | -2.74 | -3.68 | -0.17 | -11.44 |
基本平均股數(千股) | 2836.00 | 7078.00 | 6718.00 | 5799.00 | 5072.00 | - | 3838.00 | 3826.00 | 76229.00 | 76229.00 |
稀釋平均股數(千股) | 2836.00 | 7078.00 | 6718.00 | 5799.00 | 5072.00 | - | 3838.00 | 3826.00 | 76229.00 | 76229.00 |
還原基本每股稅後盈餘(元) | -2.15 | -9.22 | -36.00 | -34.00 | -28.13 | - | -137.00 | -184.00 | -174.00 | -130.00 |
還原稀釋每股稅後盈餘(元) | -2.15 | -8.35 | -36.50 | -34.50 | -28.00 | -121.07 | -137.00 | -184.00 | -174.00 | -11436.00 |
還原基本平均股數(千股) | 2,836 | 141 | 134 | 115 | 101 | - | 76 | 76 | 76 | 76 |
還原稀釋平均股數(千股) | 2,836 | 141 | 134 | 115 | 101 | - | 76 | 76 | 76 | 76 |
EBITDA(千元) | -6,081 | 494 | -4,391 | -3,929 | -5,788 | -11,448 | -10,501 | -14,060 | -13,240 | -9,674 |